Validity of ankylosing spondylitis diagnoses in The Health Improvement Network-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validity of ankylosing spondylitis diagnoses in The Health Improvement Network

Published:2016-01-13 Issue:4 Volume:25 Page:399-404
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Dubreuil Maureen¹²,Peloquin Christine³,Zhang Yuqing³,Choi Hyon K.⁴,Inman Robert D.⁵,Neogi Tuhina³

Affiliation:

1. Boston University School of Medicine; Section of Rheumatology; Boston MA USA

2. VA Boston Healthcare System; Boston MA USA

3. Boston University School of Medicine; Section of Clinical Epidemiology; Boston MA USA

4. Massachusetts General Hospital; Section of Rheumatology; Boston MA USA

5. University of Toronto; Toronto Western Hospital; Toronto ON Canada

Funder

Arthritis Foundation

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference14 articles.

1. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection;Rudwaleit;Ann Rheum Dis,2009

2. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom;Jick;BMJ,1991

3. Mining electronic health records: towards better research applications and clinical care;Jensen;Nat Rev Genet,2012

4. Medical Record Databases

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence if autoimmune inflammatory rheumatic diseases after COVID‐19 in South Korea: A nationwide cohort study based on health insurance data;International Journal of Rheumatic Diseases;2024-06

2. Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project;Clinical Epidemiology;2024-06

3. Sex Differences in Time to Initiate Nonsteroidal Anti‐Inflammatory Drugs or Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis;Arthritis Care & Research;2024-05-16

4. Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project;Pharmacological Research;2024-02

5. Epidemiologic Trends and Socioeconomic Disparities of Ankylosing Spondylitis in South Korea: A Nationwide Population-Based Study, 2010–2021;Yonsei Medical Journal;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3